1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine
C13H28FN5 — CID 170130680
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine
1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine (PubChem CID 170130680) has the molecular formula C13H28FN5 and a molecular weight of 273.40 g/mol. Its IUPAC name is 1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine.
Molecular Properties
| Compound Name | 1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine |
|---|---|
| PubChem CID | 170130680 |
| Molecular Formula | C13H28FN5 |
| Molecular Weight | 273.40 g/mol |
| Exact Mass | 273.23 |
| IUPAC Name | 1-[(1S)-3-[[2-fluoro-4-(methylamino)butyl]-methylamino]cyclopentyl]-2-methylguanidine |
| SMILES | C/N=C(\N)N[C@H]1CCC(N(C)CC(F)CCNC)C1 |
| InChI | InChI=1S/C13H28FN5/c1-16-7-6-10(14)9-19(3)12-5-4-11(8-12)18-13(15)17-2/h10-12,16H,4-9H2,1-3H3,(H3,15,17,18)/t10?,11-,12?/m0/s1 |
| InChIKey | NIWFUKKQHVMYRP-CXQJBGSLSA-N |
| XLogP | 0.32 |
| TPSA | 65.68 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 273.40 |
| LogP ≤ 5 | 0.32 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170130680 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.